The histone deacetylase inhibitors sodium butyrate and trichostatin A modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression

被引：0

作者：

VanOosten, RL ^{[1
]}

Moore, JM ^{[1
]}

Karacay, B ^{[1
]}

Griffith, TS ^{[1
]}

机构：

[1] Univ Iowa, Iowa City, IA 52242 USA

来源：

FASEB JOURNAL | 2005年 / 19卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：A1405 / A1406

页数：2

共 50 条

[41] Resistance to Apo2 Ligand (Apo2L)/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines (Retraction of vol 79, pg 1367, 2005)
Matsuda, Takehiro
Almasan, Alex
Tomita, Mariko
Uchihara, Jun-Nosuke
Masuda, Masato
Ohshiro, Kazuiku
Takasu, Nobuyuki
Yagita, Hideo
Ohta, Takao
Mori, Naoki
JOURNAL OF VIROLOGY, 2011, 85 (03) : 1416 - 1416
[42] Colorectal carcinoma cell targeting aromatherapy with Teucrium ramosissimum essential oil to sensitize TRAIL/Apo2L-induced HCT-116 cell death
Guesmi, Fatma
Tahri, Wiem
Mehrez, Amel
Barkaoui, Taha
Prasad, Sahdeo
Giuffre, Angelo Maria
Landoulsi, Ahmed
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 136
[43] RETRACTED: Resistance to apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines (Retracted Article. See vol 85, pg 1416, 2011)
Matsuda, T
Almasan, A
Tomita, M
Uchihara, J
Masuda, M
Ohshiro, K
Takasu, N
Yagita, H
Ohta, T
Mori, N
JOURNAL OF VIROLOGY, 2005, 79 (03) : 1367 - 1378
[44] Cosmc transfection decreases malignant behavior of Tn+ cells and enhances sensitivity to apoptosis when induced by Apo2L/TRAIL via alteration of O-glycan structure
Ding, Ruisong
Hu, Xingyou
Hu, Wen
Du, Zhenzhen
Huang, Panpan
Wang, Mengyang
Sheng, Jiaoyue
Ma, Yanchao
Wang, Ailing
Luan, Xiying
Dong, Menghua
Cao, Qizhi
Zou, Yanfen
Hu, Tao
AGING-US, 2021, 13 (19): : 23393 - 23406
[45] Pentoxifylline augments TRAIL/Apo2L mediated apoptosis in cutaneous T cell lymphoma (HuT-78 and MyLa) by modulating the expression of antiapoptotic proteins and death receptors
Gahlot, Satindra
Khan, Mohammad Aslam
Rishi, Loveena
Majumdar, Sekhar
BIOCHEMICAL PHARMACOLOGY, 2010, 80 (11) : 1650 - 1661
[46] Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model
Zhang, Liang
Zhang, Xiaoping
Barrisford, Glen W.
Olumi, Aria F.
CANCER LETTERS, 2007, 251 (01) : 146 - 157
[47] HGS-ETR2 (TRAIL-Receptor 2 mAb) promotes expression of TRAIL-Receptor 2 (DR5) and sequestration of c-FLIP(L) leading to tumor death in primary and metastatic renal cell carcinoma in a mouse orthotopic model
Zhang, Liang
Zhang, Xiaoping
Barrisford, Glen W.
Olumi, Aria
CANCER RESEARCH, 2006, 66 (08)
[48] Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5
Frese, S
Frese-Schaper, M
Andres, AC
Miescher, D
Zumkehr, B
Schmid, RA
CANCER RESEARCH, 2006, 66 (11) : 5867 - 5874
[49] Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein
Frese, S
Brunner, T
Gugger, M
Uduehi, A
Schmid, RA
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (01): : 168 - 174
[50] Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2
Min, Kyoung-jin
Jang, Ji Hoon
Lee, Jung Tae
Choi, Kyeong Sook
Kwon, Taeg Kyu
JOURNAL OF MOLECULAR MEDICINE-JMM, 2012, 90 (03): : 309 - 319

← 1 2 3 4 5 →